Speaker

Yvonne McGrath | Chief Scientific Officer, iTeos Therapeutics

Yvonne joined iTeos in 2020 as Vice President of Research & Development. With more than 20 years of international experience in oncology drug discovery and development, she has taken lead candidates from early stage research into clinical trials. Immediately prior to iTeos , she served as CSO and board member in Complix, a company developing novel biologics. She has also lead R&D activities in UK based biotech companies including Immunocore and Biovex. Yvonne holds a PhD from the University of Wales, College of Medicine.

About iTeos Therapeutics

iTeos Therapeutics is a clinical-stage biopharmaceutical company headquartered in Watertown, MA, with a research center in Gosselies, Belgium. Our teams work across departments, companies, and borders with a common purpose: pioneering the discovery and development of a new generation of immunotherapies for people living with cancer. We believe collaboration is critical to achieving our mission. Our team builds upon individual talents and expertise, working in synergy to bring out the best in each other—with the best people and technologies.

Powered by:
Hyphen Projects

Let's connect:

Book a ticket

FAQ
Contact Us
Privacy Policy
Terms & Conditions
Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01

Keep me informed Download our event app

© Copyright 2023 by Hyphen Projects